The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless goods represents a significant regulatory challenge for the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to act as a sedative at high dosages6. The claims made by Nicotine River, ECBlend, and various vendors that their me